Abstract
Objective:
To evaluate the impact of chorioamnionitis on the incidence of intraventricular hemorrhage in preterm neonates and to assess its impact on neurodevelopmental outcomes at 24 months of age.
Methods:
We retrospectively reviewed the medical records of all neonates <32 weeks’ gestational age born to mothers with and without histological chorioamnionitis. At 24 months of age, we evaluated long-term neurodevelopmental outcomes with the Gross Motor Function Classification System (GMFCS) and the Modified Checklist for Autism in Toddlers (M-CHAT).
Results:
Among 91 neonates with a mean gestational age of 29.1(±2.2) weeks, 54% (49 newborns) were exposed to chorioamnionitis during pregnancy. Neonates born to mothers with chorioamnionitis were of significantly lower gestational age (28.0 ± 2.3 vs. 30.2 ± 1.3 weeks, p < 0.001) and birth weight (1,172 ± 400 g vs. 1,376 ± 409 g, p = 0.018) compared to neonates born to mothers without chorioamnionitis, respectively. Neonates of mothers with chorioamnionitis had an increased risk of intraventricular hemorrhage (OR 6.34, 95% CI 1.91–21.01, p = 0.003), retinopathy of prematurity (OR 2.48, 95% CI 1.13–5.46, p = 0.041), and bronchopulmonary dysplasia (OR 6.12, 95% CI 2.08–18.04, p = 0.001). After adjusting for gestational age and intraventricular hemorrhage, chorioamnionitis had an increased risk of abnormal M-CHAT (OR 4.52, 95% CI 1.12–18.20, p = 0.034) at 24 months of age.
Conclusion:
Very preterm neonates born to mothers with chorioamnionitis are at increased risk of severe intraventricular hemorrhage, retinopathy of prematurity, bronchopulmonary dysplasia, and an increased risk of abnormal M-CHAT at 24 months of age.
Introduction
Chorioamnionitis, defined as inflammation of the chorion or amniotic membrane, often due to ascending bacterial infection, is a leading contributor to preterm birth (1). In a previous report from our site, we reported that amongst infants with suspected chorioamnionitis, the diagnosis was partially supported by histological confirmation in pregnancies of a lower gestational age (2). Preterm infants are at high risk for brain injury, among which intraventricular hemorrhage is one of the most serious. Intraventricular hemorrhage frequently originates in the germinal matrix, a fragile, highly vascularized region in the preterm brain (3). Severe intraventricular hemorrhage is strongly associated with mortality and long-term neurodevelopmental impairments (4). Given that chorioamnionitis often triggers systemic and fetal inflammatory responses, researchers have hypothesized that chorioamnionitis may predispose to intraventricular hemorrhage through multiple pathophysiological pathways, with downstream implications for neurodevelopment (5). Biological plausibility is strong, given inflammatory disruption of vascular integrity, hemodynamic instability, and coagulation abnormalities. Because intraventricular hemorrhage is itself strongly linked to neurodevelopmental impairment (e.g., cerebral palsy, cognitive delay), chorioamnionitis may exert its long-term effects largely via hemorrhagic injury. Moreover, studies adjusting for confounders show that chorioamnionitis may also have a subtler independent impact on cognition, potentially mediated by chronic neuroinflammation (6). However, not all studies are consistent: some fail to show elevated intraventricular hemorrhage or neurodevelopmental deficits in chorioamnionitis-exposed infants after adjustment (7), perhaps due to heterogeneity in definitions (clinical vs. histologic chorioamnionitis), timing of intraventricular hemorrhage assessment, or differences in postnatal care. Moreover, funisitis (histological marker of fetal inflammatory response) has not always been associated with higher intraventricular hemorrhage risk compared to chorioamnionitis without funisitis, suggesting that fetal inflammation per se may not fully account for hemorrhagic risk (1, 8).
While the association between chorioamnionitis and intraventricular hemorrhage has been previously described in several cohort studies and meta-analyses, substantial heterogeneity persists regarding the magnitude and independence of this association after adjustment for gestational age and other perinatal confounders. Furthermore, comparatively fewer studies have evaluated both neonatal morbidities and longer-term neurodevelopmental outcomes within the same histologically confirmed cohort. Therefore, this study aimed to evaluate the association between maternal histological chorioamnionitis and the development of intraventricular hemorrhage and other neonatal morbidities, namely bronchopulmonary dysplasia and retinopathy of prematurity, in very preterm neonates, as well as its association with neurodevelopmental outcomes at 24 months of age.
Methods
A retrospective cohort study was conducted in a university perinatal center over a period of 3 years (2020–2022). The medical records of neonates who were born <32 weeks of gestational age were reviewed, and neonates were classified into those born to mothers with histological chorioamnionitis and those born to mothers without evidence of chorioamnionitis. Maternal chorioamnionitis was defined according to the ACOG criteria (9); Suspected intraamniotic infection was based on clinical criteria, which included maternal intrapartum fever and one or more of the following: maternal leukocytosis, purulent cervical drainage, or fetal tachycardia. Confirmed intraamniotic infection was based on a positive amniotic fluid test result (gram stain, glucose level, or culture results consistent with infection) or placental pathology demonstrating histologic evidence of placental infection or inflammation (9). In our study, maternal chorioamnionitis was defined exclusively according to histopathological placental examination. Placental pathology reports demonstrating histologic evidence of placental inflammation or infection were considered diagnostic of histological chorioamnionitis. Histopathological evaluation was performed according to routine institutional pathology reporting practices. Maternal inflammatory response and, when available, fetal inflammatory response/funisitis findings were recorded from placental pathology reports. Because of the retrospective nature of the study, detailed staging and grading according to the Amsterdam Placental Workshop Group (10) or Redline classification (11) systems were not consistently available for all placentas. Infants without placental histologic examination or incomplete medical records were excluded. The data were anonymously recorded, and the study was approved by the ethical committee of the institution (No 2026-Β230-530/11.02.26).
Maternal data were retrospectively collected, including maternal age, mode of delivery, premature rupture of membranes, parity, antenatal administration of corticosteroids, maternal antibiotic administration, and maternal inflammatory markers, including C-reactive protein and white blood cell count prior to delivery. Neonatal data included gestational age, birthweight, sex, intrauterine growth restriction, group B Streptococcus colonization, complete course of antenatal steroids, delivery mode, need for resuscitation in the delivery room, and Apgar score. We also recorded neonatal morbidities including respiratory distress syndrome, pneumothorax, pulmonary hemorrhage, the need for inotropes administration, patent ductus arteriosus, early and late-onset sepsis, necrotizing enterocolitis, retinopathy of prematurity, intraventricular hemorrhage, and periventricular leukomalacia, based on Vermont – Oxford Network criteria (12), seizures, the duration of invasive and non-invasive mechanical ventilation, rates of bronchopulmonary dysplasia and grade based on standard criteria (13), postmenstrual age and birthweight on discharge, and survival. The long-term neurodevelopmental outcome was evaluated at 24 months of age with the Gross Motor Function Classification System (GMFCS) and the Modified Checklist for Autism in Toddlers (M-CHAT). The GMFCS is considered a standardized way to describe gross motor abilities and a reliable measure for functional severity (14), while the M-CHAT is the most commonly used toddler screener for autism spectrum disorder; in a recent review including 50 studies, the pooled sensitivity of M-CHAT was 0.83 (95% CI, 0.77–0.88), and the pooled specificity was 0.94 (95% CI, 0.89–0.97) (15).
The primary outcome included the association of chorioamnionitis with the development of intraventricular hemorrhage and common neonatal morbidities, including bronchopulmonary dysplasia and retinopathy of prematurity. The secondary outcomes included the correlation of an abnormal M-CHAT with maternal chorioamnionitis, adjusted for gestational age and intraventricular hemorrhage.
Statistical analysis
Descriptive statistics were calculated for maternal and neonatal characteristics. The normality of the distributions of continuous variables was assessed with the Shapiro–Wilk normality test. Continuous variables were expressed as mean ± standard deviation or median (interquartile range), and categorical variables as n (percentage %). Comparisons between continuous variables were performed with the student's t-test, or the non-parametric Mann–Whitney test, as appropriate, whereas comparisons between categorical variables utilized the chi-square test or Fisher's exact test.
A multivariate logistic regression analysis was performed to examine the association of intraventricular hemorrhage, bronchopulmonary dysplasia, retinopathy of prematurity, and seizures with maternal chorioamnionitis, adjusted for gestational age. Given the relatively limited sample size and event rates, additional adjustment for multiple postnatal variables was avoided to minimize model overfitting. A separate multivariate logistic regression analysis examined the association of abnormal M-CHAT findings at 24 months of age with maternal chorioamnionitis after adjustment for gestational age and intraventricular hemorrhage. The Bonferroni correction for multiple testing was utilized. Collinearity was examined with a correlation matrix, and variables with significant collinearity, such as gestational age and birth weight, were examined separately in the model. All tests were two-sided, and a p-value less than 0.05 was considered statistically significant (alpha 0.05). The data were analyzed using SPSS Statistics Version 25.0 (IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY, US).
Results
In a sample of 91 neonates with a mean gestational age of 29.1 ± 2.2 weeks and birth weight of 1,266 ± 415 g, 54% (49 newborns) were exposed to chorioamnionitis during pregnancy (Figure 1). Neonates born to mothers with chorioamnionitis were of significantly lower gestational age (28.0 ± 2.3 vs. 30.2 ± 1.3 weeks, p < 0.001) and birth weight (1,172 ± 400 g vs. 1,376 ± 409 g, p = 0.018) compared to neonates born to mothers without chorioamnionitis, respectively (Table 1). Maternal antenatal antibiotic administration was significantly more frequent in the chorioamnionitis group compared to the non-chorioamnionitis group (56% vs. 28%, p = 0.005). Maternal C-reactive protein levels prior to delivery were higher in mothers with histological chorioamnionitis compared to mothers without chorioamnionitis [1.54 (0.51–3.30) vs. 0.91 (0.53–1.20) mg/dL, p = 0.001]. Moreover, neonates born to mothers with chorioamnionitis, compared to those without chorioamnionitis, developed at higher rates intraventricular hemorrhage (32% compared to 10%, p = 0.011), retinopathy of prematurity (16% compared to 2%, p = 0.033), and bronchopulmonary dysplasia (36% compared to 14%, p = 0.013). Of the 91 neonates, 4 (4%) neonates born to mothers with chorioamnionitis had a severe intraventricular hemorrhage (III-IV) (Table 2).
Figure 1
Table 1
| Variables | Total cohort (n-91) | Chorioamnionitis (n = 49) | Non-chorioamnionitis (n = 42) | p |
|---|---|---|---|---|
| Gestational age, weeks | 29.1 ± 2.2 | 28.0 ± 2.3 | 30.2 ± 1.3 | <0.001 |
| Birth weight, g | 1,266 ± 415 | 1,172 ± 400 | 1,376 ± 409 | 0.018 |
| Sex, male | 49 (54%) | 22 (44%) | 27 (64%) | 0.141 |
| Maternal age, years | 32.6 ± 8.1 | 33.8 ± 8.0 | 31.0 ± 8.0 | 0.194 |
| In-vitro fertilization | 22 (24%) | 9 (18%) | 13 (31%) | 0.226 |
| Primiparity | 62 (68%) | 38 (76%) | 24 (57%) | 0.082 |
| Cesarean section | 84 (92%) | 43 (86%) | 41 (98%) | 0.118 |
| Prolonger rupture of membranes | 21 (23%) | 14 (28%) | 7 (17%) | 0.217 |
| Antenatal antibiotic administration | 40 (44%) | 28 (56%) | 12 (28%) | 0.005 |
| Antenatal steroid administration | 68 (74%) | 35 (70%) | 33 (79%) | 0.989 |
| Maternal C-reactive protein, mg/dL | 1.04 (0.52–1.87) | 1.54 (0.51–3.30) | 0.91 (0.53–1.20) | 0.001 |
| Maternal white blood cells, cells/μL | 13,100 (10,500–16,200) | 15,300 (11,300–17,900) | 12,400 (10,100–13,100) | 0.037 |
| Apgar 1st minute | 7 (6–8) | 7 (6–8) | 7 (7–8) | 0.194 |
| Apgar 5th minute | 8 (8–9) | 8 (8–9) | 8 (8–9) | 0.997 |
Perinatal characteristics of the study cohort and between neonates born to mothers with chorioamnionitis vs. neonates born to mothers without chorioamnionitis.
Continuous variables are expressed as mean ± standard deviation or median (interquartile range). P-value of the student's t-test or the Mann–Whitney U test. Categorical variables are expressed as n (%). P-value of the chi-square test.
Table 2
| Variables | Total cohort (n-91) | Chorioamnionitis (n = 49) | Non-chorioamnionitis (n = 42) | p |
|---|---|---|---|---|
| Respiratory distress syndrome | 57 (63%) | 31 (62%) | 26 (62%) | 0.819 |
| Transient tachypnea | 5 (5%) | 2 (4%) | 3 (7%) | 0.664 |
| Persistent pulmonary hypertension | 2 (2%) | 1 (2%) | 1 (2%) | 0.989 |
| Emphysema | 3 (3%) | 3 (6%) | - | 0.242 |
| Early-onset sepsis | 12 (13%) | 9 (18%) | 3 (7%) | 0.212 |
| Late-onset sepsis | 36 (40%) | 19 (38%) | 17 (40%) | 0.998 |
| Patent ductus arteriosus | 20 (22%) | 12 (24%) | 8 (19%) | 0.458 |
| Necrotizing enterocolitis | 5 (5%) | 2 (4%) | 3 (7%) | 0.660 |
| Retinopathy of prematurity | 9 (10%) | 8 (16%) | 1 (2%) | 0.033 |
| Bronchopulmonary dysplasia | 24 (26%) | 18 (36%) | 6 (14%) | 0.013 |
| Intraventricular hemorrhage | 20 (22%) | 16 (32%) | 4 (10%) | 0.011 |
| Severe intraventricular hemorrhage | 4 (4%) | 4 (8%) | - | 0.121 |
| Intraventricular hemorrhage, grade | 0.011 | |||
| I | 13 (13%) | 9 (18%) | 4 (10%) | |
| II | 3 (3%) | 3 (6%) | - | |
| III | 2 (2%) | 2 (4%) | - | |
| IV | 2 (2%) | 2 (4%) | - | |
| Periventricular leukomalacia | 1 (1%) | 1 (2%) | - | 0.987 |
| Seizures | 4 (4%) | 4 (8%) | - | 0.121 |
| Survival | 83 (91%) | 42 (84%) | 41 (98%) | 0.065 |
| Hypotonia at discharge | 31 (34%) | 19 (38%) | 12 (29%) | 0.171 |
| MRI, abnormal | 13 (14%) | 8 (16%) | 5 (12%) | 0.540 |
| GMFCS, abnormal | 3 (3%) | 3 (6%) | - | 0.245 |
| M-CHAT, abnormal | 11 (12%) | 9 (18%) | 2 (5%) | 0.047 |
Outcomes of the study cohort and between neonates born to mothers with chorioamnionitis vs. neonates born to mothers without chorioamnionitis.
Categorical variables are expressed as n (%). P-value of the chi-square test.
MCHAT, Modified Checklist for Autism in Toddlers; GMFCS, Gross Motor Function Classification System; MRI, Magnetic Resonance Image.
Neonates born to mothers with chorioamnionitis had an abnormal brain MRI at term-equivalent age in 16% vs. 12% of neonates born to mothers without (p = 0.540). At 24 months of age, three (6%) neonates of mothers with chorioamnionitis had an abnormal GMFCS (vs no neonate without chorioamnionitis, p = 0.245), and nine (18%) neonates with vs two (5%) without chorioamnionitis had abnormal M-CHAT (p = 0.047) (Table 2).
After adjusting for gestational age, neonates born to mothers with chorioamnionitis had an increased risk of intraventricular hemorrhage (OR 6.34, 95% CI 1.91–21.01, p = 0.003), retinopathy of prematurity (OR 2.48, 95% CI 1.13–5.46, p = 0.041), and bronchopulmonary dysplasia (OR 6.12, 95% CI 2.08–18.04, p = 0.001), compared to neonates born to mothers without chorioamnionitis. Also, after adjusting for gestational age and intraventricular hemorrhage, chorioamnionitis had an increased risk of abnormal M-CHAT (OR 4.52, 95% CI 1.12–18.20, p = 0.034) at 24 months of age (Table 3).
Table 3
| Variables | OR | 95% CI | p |
|---|---|---|---|
| Intraventricular hemorrhage | |||
| Chorioamnionitis | 6.34 | 1.91–21.01 | 0.003 |
| Gestational age | 0.85 | 0.79–0.92 | 0.001 |
| Retinopathy of prematurity | |||
| Chorioamnionitis | 2.48 | 1.13–5.46 | 0.041 |
| Gestational age | 0.76 | 0.61–0.94 | 0.014 |
| Bronchopulmonary dysplasia | |||
| Chorioamnionitis | 6.12 | 2.08–18.04 | 0.001 |
| Gestational age | 0.87 | 0.82–0.93 | <0.001 |
| Abnormal M-CHAT | |||
| Chorioamnionitis | 4.52 | 1.12–18.20 | 0.034 |
| Gestational age | 0.83 | 0.75–0.91 | 0.005 |
| Intraventricular hemorrhage | 2.03 | 0.41–10.09 | 0.384 |
Multivariate logistic regression analysis of the association of intraventricular hemorrhage, bronchopulmonary dysplasia, retinopathy of prematurity, and seizures with chorioamnionitis, adjusted for gestational age, and abnormal M-CHAT at 24 months of age adjusted for gestational age and intraventricular hemorrhage.
MCHAT, Modified Checklist for Autism in Toddlers; GMFCS, Gross Motor Function Classification System; MRI, Magnetic Resonance Image; OR, odds ratio; CI, confidence intervals.
Discussion
The findings of our study suggested that preterm neonates born to mothers with histological chorioamnionitis are at increased risk of intraventricular hemorrhage, retinopathy of prematurity, and bronchopulmonary dysplasia. Also, preterm neonates born to mothers with histological chorioamnionitis are at increased risk of an abnormal M-CHAT at 24 months of age, after adjustment for gestational age and intraventricular hemorrhage. While the association between chorioamnionitis and intraventricular hemorrhage has been previously described, our study contributes contemporary data from a histologically confirmed cohort and additionally explores early neurodevelopmental screening outcomes.
Our findings align with previous evidence suggesting a strong association between chorioamnionitis and intraventricular hemorrhage. A systematic review and meta-analysis by Villamor-Martinez et al. included 85 studies and over 46,000 infants; exposure to chorioamnionitis was associated with significantly increased odds of all grades of intraventricular hemorrhage (OR 1.88, 95% CI 1.61–2.19), of mild intraventricular hemorrhage (grades I–II; OR 1.69, 95% CI 1.22–2.34), and of severe intraventricular hemorrhage (grades III–IV; OR 1.62, 95% CI 1.42–1.85) (1). Importantly, the association persisted even after adjusting for confounders such as gestational age and birth weight, suggesting that chorioamnionitis imparts risk beyond simply inducing earlier delivery (1). A broader meta-analysis of antenatal infection and intraventricular hemorrhage supports similar findings: antenatal infection (most commonly chorioamnionitis) was associated with a higher risk of both mild (OR 1.95) and severe (OR 2.65) intraventricular hemorrhage, independent of gestational age (meta-analysis of 23 cohort studies with 13,605 infants; OR for infection overall 2.18) (16). Additionally, a cohort study of infants born to mothers with preterm premature rupture of membranes found that maternal chorioamnionitis was an independent risk factor for intraventricular hemorrhage, after controlling for gestational age and other perinatal variables (17). Of note, an earlier, smaller study examining extremely preterm infants (<28 weeks of gestational age) found no significant difference in early-onset intraventricular hemorrhage (within 72 h) between infants with histological chorioamnionitis and those without (14.5% vs. 18.2%; p = 0.48), disputing the association (18). Nevertheless, the majority of the evidence and the weight of evidence from large-scale meta-analyses support a positive and clinically meaningful association.
Several plausible mechanistic pathways connect chorioamnionitis to intraventricular hemorrhage. First, systemic fetal inflammation (i.e., the fetal inflammatory response syndrome) leads to elevated proinflammatory cytokines—such as interleukin-6 (IL-6), IL-1β, and tumor necrosis factor-α (TNF-α)—in the fetal circulation (19). These cytokines can impair vascular stability by weakening endothelial tight junctions, promoting endothelial activation, and perturbing vascular reactivity (19). The germinal matrix microvasculature in preterm infants is particularly fragile, lacking fully mature autoregulation, making it vulnerable to such inflammatory insults. Second, inflammation may disrupt cerebral autoregulation and hemodynamics. Inflammatory mediators may induce vascular tone dysregulation, hypotension, or fluctuations in cerebral blood flow (3, 20). Meta-analytic data revealed a correlation between chorioamnionitis, patent ductus arteriosus, and intraventricular hemorrhage; a hemodynamically significant patent ductus arteriosus might further destabilize cerebral circulation, increasing hemorrhage risk (1). Third, inflammation can affect coagulation; chorioamnionitis has been associated with coagulopathy in neonates, including thrombocytopenia and altered clotting factors, which may exacerbate hemorrhagic vulnerability (21). Finally, direct neuroinflammatory effects in the brain may contribute: cytokines can cross or signal at the blood-brain barrier, activate microglia, and trigger endothelial and glial cell adhesion molecule expression, leading to leukocyte–platelet interactions, endothelial damage, and increased blood viscosity or rheologic instability (22, 23). Additional studies support this association. Huang et al. demonstrated in a meta-analysis of 23 cohort studies including 13,605 infants that antenatal infection was independently associated with both mild and severe intraventricular hemorrhage (16). Similarly, Lu et al. identified maternal chorioamnionitis as an independent predictor of intraventricular hemorrhage in infants born after preterm premature rupture of membranes (17). Although some smaller studies failed to demonstrate a significant association after adjustment (24, 25), the overall body of evidence supports a biologically plausible relationship between antenatal inflammation and hemorrhagic brain injury in very preterm neonates (1, 8).
Apart from intraventricular hemorrhage, chorioamnionitis was also associated with bronchopulmonary dysplasia and retinopathy of prematurity in our cohort. Chorioamnionitis is repeatedly linked to adverse neonatal outcomes, including bronchopulmonary dysplasia and—less consistently—retinopathy of prematurity. Multiple systematic reviews and meta-analyses report that chorioamnionitis exposure increases the risk of bronchopulmonary dysplasia in very preterm infants, although much of this association is mediated by earlier gestational age and greater respiratory immaturity among chorioamnionitis-exposed neonates (26). The biological plausibility for chorioamnionitis-associated bronchopulmonary dysplasia includes antenatal inflammatory priming of the fetal lung, dysregulated pulmonary vascular and alveolar development, and interaction with postnatal insults (ventilation, oxygen). Recent cohort and histopathology studies support an independent effect of severe histologic chorioamnionitis on later bronchopulmonary dysplasia risk, but the effect size varies across studies after adjusting for confounders (27). For retinopathy of prematurity, systematic reviews show mixed findings: several meta-analyses found an association between chorioamnionitis and increased retinopathy of prematurity risk, but heterogeneity and confounding (prematurity, oxygen therapy, sepsis) complicate causal inference (28, 29). Some pooled analyses suggest a modest increased odds of any-stage retinopathy of prematurity with chorioamnionitis exposure, while others conclude the relationship weakens after rigorous adjustment (29). Interestingly, a recent meta-analysis revealed a negative association between chorioamnionitis and retinopathy of prematurity, suggesting a possible protective effect of chorioamnionitis against severe ROP, potentially mediated by inflammatory markers (30). In our study, regression analyses were adjusted primarily for gestational age because of sample size limitations and concern for model overfitting. Therefore, residual confounding from postnatal respiratory support, oxygen exposure, steroid administration, and sepsis cannot be excluded, and these findings should be interpreted cautiously.
Another significant finding in our study is that chorioamnionitis is associated with an abnormal M-CHAT at 24 months of age. The association of chorioamnionitis with the neurodevelopmental outcome was significant even after adjusting for the gestational age and the development of intraventricular hemorrhage. Intraventricular hemorrhage, especially high-grade (Grade III–IV), is a robust predictor of adverse neurodevelopmental outcomes. A recent study of preterm infants assessing early neurodevelopment (3–4 months corrected age) found that severe intraventricular hemorrhage increased the odds of cerebral palsy/high-risk of cerebral palsy diagnosis (adjusted OR 6.07 for severe intraventricular hemorrhage; OR 15.3 for severe brain injury, including intraventricular hemorrhage or cystic periventricular leukomalacia) (31). These early neurological assessments often portend later motor disability, cognitive deficits, and cerebral palsy. Beyond hemorrhagic injury, chorioamnionitis-related inflammation may independently impair neurodevelopment. One large multicentre cohort of 350 preterm infants assessed the association of histologic chorioamnionitis with neurodevelopment at 18–24 months corrected age (7). While chorioamnionitis was not significantly associated with intraventricular hemorrhage or punctate white matter injury after risk adjustment, there was a small, marginal reduction in cognitive performance (adjusted Bayley-III cognitive score difference −3.0, 95% CI −6.4 to 0.4), though motor scores did not differ significantly (adjusted difference −2.2, 95% CI −5.6 to 1.3) (7). Also, a previous study of 197 infants revealed that histological chorioamnionitis was associated with poorer cognitive outcome and weaker memory and learning function at 5 years of age (32). On the other hand, a study of 177 very low-birth-weight infants suggested a higher incidence of intraventricular hemorrhage and retinopathy of prematurity but similar neurodevelopmental scores and risk of cerebral palsy associated with chorioamnionitis (33). These findings suggest that although chorioamnionitis may increase intraventricular hemorrhage risk, its direct effect on early neurodevelopment, once perinatal confounders are considered, might be more modest than previously thought. Although we observed an association between chorioamnionitis and abnormal M-CHAT findings at 24 months of age, the relatively small number of abnormal outcomes and the wide confidence intervals suggest substantial statistical imprecision. Furthermore, M-CHAT and GMFCS represent screening and functional assessment tools rather than comprehensive neurodevelopmental testing. Consequently, these findings should be interpreted cautiously and considered exploratory and hypothesis-generating. Larger prospective studies with standardized neurodevelopmental assessments and longer follow-up are required to clarify the long-term neurodevelopmental impact of histological chorioamnionitis.
Overall, the evidence indicates that chorioamnionitis is a significant risk factor for intraventricular hemorrhage in preterm infants, with meta-analyses showing consistently elevated odds across intraventricular hemorrhage severity grades (1, 16). Recognizing chorioamnionitis as a risk factor for intraventricular hemorrhage has practical implications. Obstetric management of suspected or confirmed chorioamnionitis should remain aggressive, including timely antibiotic therapy and judicious decisions about the timing of delivery. In the neonatal period, infants born after chorioamnionitis exposure may benefit from heightened surveillance (e.g., early cerebral ultrasound) and rigorous strategies to maintain hemodynamic stability, minimize fluctuations in cerebral blood flow, and avoid coagulopathy. Furthermore, identifying chorioamnionitis-exposed infants, especially those with biomarkers of fetal inflammatory response, might help neonatologists stratify risk and apply neuroprotective strategies (such as early interventions, neuro-monitoring, or inflammation-modulating therapies).
The limitations of our study should be acknowledged. First, this was a single-centre retrospective study, and therefore, the findings should be interpreted cautiously before generalization to broader populations. Second, the number of severe intraventricular hemorrhage cases and abnormal neurodevelopmental outcomes was limited, reducing statistical power for these clinically important outcomes. Third, although analyses were adjusted for gestational age, residual confounding related to postnatal respiratory support, oxygen exposure, postnatal steroid administration, and sepsis may have influenced bronchopulmonary dysplasia and retinopathy of prematurity outcomes. Fourth, detailed placental histopathological staging and grading according to standardized international classification systems were not consistently available because of the retrospective design. Finally, neurodevelopmental assessment relied on screening and functional assessment tools rather than formal comprehensive neurodevelopmental testing. Only a few neonates reported an abnormal MRI and GMFCS score at 12 months of age, which could be attributed to the time of the follow-up assessment. The clinical findings of cerebral palsy are usually evident later than 24 months of age, and thus, some neonates might not have developed abnormal clinical signs at the time of the assessment.
In conclusion, histological chorioamnionitis appears to be associated with increased risk of intraventricular hemorrhage, bronchopulmonary dysplasia, and retinopathy of prematurity in very preterm neonates, independent of gestational age. Exposure to histological chorioamnionitis was additionally associated with abnormal M-CHAT findings at 24 months of age; however, these neurodevelopmental findings require cautious interpretation and validation in larger prospective studies with formal long-term neurodevelopmental assessment. Further research is needed to clarify the underlying inflammatory and hemodynamic mechanisms linking chorioamnionitis with neonatal brain injury and adverse developmental outcomes. Longitudinal neurodevelopmental follow-up into childhood is also essential to assess whether early subtle deficits in cognition or behavior persist or evolve. Neuroimaging studies might help elucidate structural changes (e.g., white matter injury) in relation to chorioamnionitis and intraventricular hemorrhage.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation available upon reasonable request.
Ethics statement
The studies involving humans were approved by Ethics Committee of Papageorgiou Hospital (2026-Β230-530/11.02.26). The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants’ legal guardians/next of kin because That was an anonymous retrospective data review study.
Author contributions
ED: Data curation, Project administration, Software, Writing – review & editing. DR: Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing. ML: Writing – review & editing. GK: Writing – review & editing. EA: Writing – review & editing. IC: Writing – review & editing. AA: Writing – review & editing. CT: Supervision, Validation, Visualization, Writing – review & editing.
Funding
The author(s) declared that financial support was not received for this work and/or its publication.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
Villamor-MartinezEFumagalliMMohammed RahimOPasseraSCavallaroGDegraeuwePet al. Chorioamnionitis is a risk factor for intraventricular hemorrhage in preterm infants: a systematic review and meta-analysis. Front Physiol. (2018) 9(1253):1–17. 10.3389/fphys.2018.01253
2.
RallisDLithoxopoulouMPervanaSKaragianniPHatziioannidisISoubasiVet al. Clinical chorioamnionitis and histologic placental inflammation: association with early-neonatal sepsis. J Matern Fetal Neonatal Med. (2022) 35(25):8090–96. 10.1080/14767058.2021.1961727
3.
InderTEPerlmanJMVolpeJJ.Preterm Intraventricular Hemorrhage/Posthemorrhagic Hydrocephalus. In: Volpe's Neurology of the Newborn. 6th ed. Philadelphia: Elsevier (2018). p. 637–98.e21. 10.1016/B978-0-323-42876-7.00024-7
4.
ReesPGaleCBattersbyCWilliamsCCarterBSutcliffeA. Intraventricular hemorrhage and survival, multimorbidity, and neurodevelopment. JAMA Netw. Open. (2025) 8(1):1–14. 10.1001/jamanetworkopen.2024.52883
5.
TsamantiotiELisonkovaSMuracaGÖrtqvistAKRazazN. Chorioamnionitis and risk of long-term neurodevelopmental disorders in offspring: a population-based cohort study. Am J Obstet Gynecol. (2022) 227(2):287.e1–87.E17. 10.1016/j.ajog.2022.03.028
6.
CarterSWDNeubronnerSSuLLDashraathPMattarCIllanesSEet al. Chorioamnionitis: an update on diagnostic evaluation. Biomedicines. (2023) 11(11):2922. 10.3390/biomedicines11112922
7.
BierstoneDWagenaarNGanoDLGuoTGeorgioGGroenendaalFet al. Association of histologic chorioamnionitis with perinatal brain injury and early childhood neurodevelopmental outcomes among preterm neonates. JAMA Pediatr. (2018) 172(6):534–41. 10.1001/jamapediatrics.2018.0102
8.
HundscheidTMHuizingMJVillamor-MartinezEBartošFVillamorE. Association of funisitis with short-term outcomes of prematurity: a frequentist and Bayesian meta-analysis. Antioxidants. (2023) 12(2):534. 10.3390/antiox12020534
9.
ACOG. Committee Opinion No. 712: intrapartum management of intraamniotic infection. Obstet Gynecol. (2017) 130(2):e95–e101. 10.1097/aog.0000000000002236
10.
KhongTYKimCJRogersBB. Amsterdam Placental workshop group consensus statement definitions revisited: basal chronic villitis. Virchows Arch. (2025) 487(3):501–09. 10.1007/s00428-025-04152-z
11.
RedlineRW. Classification of placental lesions. Am J Obstet Gynecol. (2015) 213(4):S21–8. 10.1016/j.ajog.2015.05.056
12.
Vermont-Oxford Network. Manual of Operations: Part 2 Data Definitions & Infant Data Forms. Release 23.2 Published February 2019. Vermont (2019).
13.
HigginsRDJobeAHKoso-ThomasMBancalariEViscardiRMHartertTVet al. Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr. (2018) 197:300–08. 10.1016/j.jpeds.2018.01.043
14.
PalisanoRJ. Classification of functional abilities of children and adolescents with cerebral palsy. Dev Med Child Neurol. (2021) 63(11):1242–42. 10.1111/dmcn.14928
15.
WieckowskiATWilliamsLNRandoJLyallKRobinsDL. Sensitivity and specificity of the modified checklist for autism in toddlers (original and revised). JAMA Pediatr. (2023) 177(4):373–83. 10.1001/jamapediatrics.2022.5975
16.
HuangJMengJChoonaraIXiongTWangYWangHet al. Antenatal infection and intraventricular hemorrhage in preterm infants. Medicine (Baltimore). (2019) 98(31):1–10. 10.1097/md.0000000000016665
17.
LuHWangQLuJZhangQKumarP. Risk factors for intraventricular hemorrhage in preterm infants born at 34 weeks of gestation or less following preterm premature rupture of membranes. J Stroke Cerebrovasc Dis. (2016) 25(4):807–12. 10.1016/j.jstrokecerebrovasdis.2015.12.011
18.
SarkarSKaplanCWiswellTESpitzerAR. Histological chorioamnionitis and the risk of early intraventricular hemorrhage in infants born ≤28 weeks gestation. J Perinatol. (2005) 25(12):749–52. 10.1038/sj.jp.7211399
19.
JungERomeroRYeoLDiaz-PrimeraRMarin-ConchaJParaRet al. The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications. Semin. Fetal Neonatal Med. (2020) 25(4):101146. 10.1016/j.siny.2020.101146
20.
PoryoMBoeckhJCGortnerLZemlinMDuppréPEbrahimi-FakhariDet al. Ante-, peri- and postnatal factors associated with intraventricular hemorrhage in very premature infants. Early Hum Dev. (2018) 116:1–8. 10.1016/j.earlhumdev.2017.08.010
21.
MoiseiwitschNBrownAC. Neonatal coagulopathies: a review of established and emerging treatments. Exp Biol Med. (2021) 246(12):1447–57. 10.1177/15353702211006046
22.
YanowitzTDJordanAGilmourJTowbinCHBowenRRobertsADet al. Hemodynamic disturbances in premature infants born after chorioamnionitis: association with cord blood cytokine concentrations. Pediatr Res. (2002) 51(3):310–16. 10.1203/00006450-200203000-00008
23.
Gryka-MartonMGrabowskaADSzukiewiczD. Breaking the barrier: the role of proinflammatory cytokines in bbb dysfunction. Int J Mol Sci. (2025) 26(8):3532. 10.3390/ijms26083532
24.
SuppiejAFranzoiMVedovatoSMaruccoAChiarelliSZanardoV. Neurodevelopmental outcome in preterm histological chorioamnionitis. Early Hum Dev. (2009) 85(3):187–89. 10.1016/j.earlhumdev.2008.09.410
25.
DempseyEChenMFKokottisTVallerandDUsherR. Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis. Am J Perinatol. (2005) 22(03):155–59. 10.1055/s-2005-865020
26.
Villamor-MartinezEÁlvarez-FuenteMGhaziAMTDegraeuwePZimmermannLJIKramerBWet al. Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants. JAMA Netw. Open. (2019) 2(11):1–21. 10.1001/jamanetworkopen.2019.14611
27.
CostaSFattoreSDe SantisMLanzoneASpanuTArenaVet al. Effect of acute histologic chorioamnionitis on bronchopulmonary dysplasia and mortality rate among extremely low gestational age neonates: a retrospective case–control study. Int J Gynaecol Obstet. (2023) 165(3):1040–46. 10.1002/ijgo.15290
28.
BahmaniTKarimiARezaeiNDaliriS. Retinopathy prematurity: a systematic review and meta-analysis study based on neonatal and maternal risk factors. J Matern Fetal Neonatal Med. (2021) 35(25):8032–50. 10.1080/14767058.2021.1940938
29.
Villamor-MartinezECavallaroGRaffaeliGMohammed RahimOMMGuldenSGhaziAMTet al. Chorioamnionitis as a risk factor for retinopathy of prematurity: an updated systematic review and meta-analysis. PLoS One. (2018) 13(10):1–20. 10.1371/journal.pone.0205838
30.
YoonYMShinSHParkC-wKimE-KKimH-S. Correlation between histologic chorioamnionitis and severe retinopathy of prematurity. Pediatr Res. (2025) 98:2139–43. 10.1038/s41390-025-04093-y
31.
NgNSRazakAChandrasekharanPMcLeanGSackettVZhouLet al. Early neurodevelopmental outcomes of preterm infants with intraventricular haemorrhage and periventricular leukomalacia. J Paediatr Child Health. (2024) 60(11):669–74. 10.1111/jpc.16654
32.
YlijokiMLehtonenLLindAEkholmELapinleimuHKujariHet al. Chorioamnionitis and five-year neurodevelopmental outcome in preterm infants. Neonatology. (2016) 110(4):286–95. 10.1159/000446236
33.
PolamSKoonsAAnwarMShen-SchwarzSHegyiT. Effect of chorioamnionitis on neurodevelopmental outcome in preterm infants. Arch Pediatr Adolesc Med. (2005) 159(11):1032–5. 10.1001/archpedi.159.11.1032
Summary
Keywords
cerebral palsy, funisitis, intrauterine infection, neurodevelopment, prematurity
Citation
Drogouti E, Rallis D, Lithoxopoulou M, Kerpiniotis G, Aggeli E, Chatziioannidis I, Athanasiadis A and Tsakalidis C (2026) The association of chorioamnionitis with intraventricular hemorrhage and long-term outcome in very preterm neonates. Front. Pediatr. 14:1829713. doi: 10.3389/fped.2026.1829713
Received
13 March 2026
Revised
17 May 2026
Accepted
29 May 2026
Published
15 June 2026
Volume
14 - 2026
Edited by
Simone Pratesi, University of Florence, Italy
Reviewed by
Vignesh Gunasekaran, West Virginia University, United States
Eleanor Jeffreys, King's College London, United Kingdom
Updates
Copyright
© 2026 Drogouti, Rallis, Lithoxopoulou, Kerpiniotis, Aggeli, Chatziioannidis, Athanasiadis and Tsakalidis.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Dimitrios Rallis drallis@auth.gr
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.